Courts

101 - 120 of 733 Results

  • What the Health? From ϳԹ News

    A Colorful Cast Could Lead Key Health Agencies

    Episode 375

    President-elect Donald Trump has made his choices to fill some top jobs at the Department of Health and Human Services. They include controversial figures who were vocal critics of the Biden administration’s handling of the covid pandemic and have proposed sweeping changes to the agencies they would lead. Meanwhile, the Supreme Court heard its first two health-related cases of the term, challenging a Tennessee law barring transgender medical care for minors and, separately, challenging the FDA’s handling of e-cigarettes. Joanne Kenen of the Johns Hopkins University and Politico, Shefali Luthra of The 19th, and Sarah Karlin-Smith of the Pink Sheet join ϳԹ News’ Julie Rovner to discuss these stories and more. Also this week, Rovner interviews ϳԹ News’ Bram Sable-Smith, who reported and wrote the latest ϳԹ News-Washington Post Well+Being “Bill of the Month” feature, about an emergency room bill for a visit that didn’t get past the waiting room.

    Listen Now
  • What the Health? From ϳԹ News

    Trump’s Nontraditional Health Picks

    Episode 373

    Not only has President-elect Donald Trump chosen prominent vaccine skeptic Robert F. Kennedy Jr. to lead the Department of Health and Human Services, Trump also has said he will nominate controversial TV host Mehmet Oz to run the Centers for Medicare & Medicaid Services, which oversees coverage for nearly half of Americans. Meanwhile, the lame-duck Congress is back in Washington with just a few weeks to figure out how to wrap up work for the year. Rachel Cohrs Zhang of Stat, Sandhya Raman of CQ Roll Call, and Riley Ray Griffin of Bloomberg News join ϳԹ News’ Julie Rovner to discuss these stories and more. Also this week, Rovner interviews Sarah Varney, who has been covering a trial in Idaho challenging the lack of medical exceptions in that state’s abortion ban.

    Listen Now
  • What the Health? From ϳԹ News

    Trump 2.0

    Episode 371

    As Donald Trump readies for his return to the White House — with the backing of a GOP majority in the Senate and, possibly, the House — the entire health care industry is waiting to see what happens next. Clearly on the agenda: the future of abortion and reproductive rights, Medicare, Medicaid, the Affordable Care Act, and public health’s infrastructure. Rachel Cohrs Zhang of Stat and Alice Miranda Ollstein of Politico join ϳԹ News’ Julie Rovner to discuss these stories and more. Also this week, Rovner interviews ϳԹ News’ Jackie Fortiér, who reported and wrote the latest ϳԹ News-Washington Post “Bill of the Month” feature, about a 2-year-old who had a very expensive run-in with a rattlesnake.

    Listen Now
  • What the Health? From ϳԹ News

    Yet Another Promise for Long-Term Care Coverage

    Episode 367

    As part of her presidential campaign, Vice President Kamala Harris has rolled out a plan for Medicare to provide in-home long-term care services. The proposal would fill a longtime need for families trying to simultaneously care for young children and older parents, but its enormous price tag makes it a promise unlikely to be fulfilled. Meanwhile, a growing number of Republican candidates up and down the ballot facing voter backlash over their support for abortion restrictions are trying to reinvent their positions. Shefali Luthra of The 19th, Jessie Hellmann of CQ Roll Call, and Joanne Kenen of Johns Hopkins University and Politico join ϳԹ News’ Julie Rovner to discuss these stories and more. Also this week, excerpts from a KFF lunch with “Shark Tank” panelist and generic drug discounter Mark Cuban, who has been consulting with the Harris campaign about health care issues.

    Listen Now
  • A roll of one hundred dollar bills sits among a row of prescription medication bottles.

    California May Regulate and Restrict Pharmaceutical Brokers

    California lawmakers are moving to rein in the pharmaceutical middlemen they say drive up costs and limit consumers’ choices. The bill sent to Gov. Gavin Newsom would require pharmacy benefit managers to be licensed in California and would ban some business practices. Newsom vetoed a previous effort three years ago.